South America News
Found 1,623 articles
Genomma Lab Internacional, S.A.B. de C.V., one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, provides a preliminary overview of 2023 full year performance relative to hyperinflationary accounting for its Argentina subsidiary.
Freudenberg Medical, a global contract design and manufacturing partner to the medical device and biopharma industry with facilities in key industry hubs across the Americas, Europe and Asia, announced it is to establish a second manufacturing site in Costa Rica.
Pharma-Bio Serv, Inc. announced that revenues for the year ended October 31, 2023 were approximately $17.0 million, a decrease of approximately $2.4 million when compared to last year.
PhageLab Raises $11 Million to Develop Bacteriophage Solutions to Treat Bacterial Outbreaks in the Livestock Industry
PhageLab announced a $11 million funding round with investment from Nazca, Collaborative Fund, Water Lemon Ventures and individual investor Kevin Efrusy.
Procaps Group, S.A. announced its financial results for the three months ended September 30, 2023 and the nine months ended September 30, 2023.
Interviews can be difficult in any field, but especially in a competitive industry like the life sciences. Read on to discover the best way to answer salary interview questions in our guide.
Genomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange declaring a cash dividend of $0.196080 Mexican pesos per share on its common stock representing a total amount of $200,001,600.00 M.N., payable to shareholders of record of the applicable circulating shares at the close of business on December 27, 2023.
MGI Tech Co. Ltd., a company committed to building core tools and technology to lead life science, announced partnerships with Genos Médica, a Mexico-based specialized center in genomics, and TCL Group, a company dedicated to the import and sales of laboratory equipment and supplies in Chile, respectively.
Procaps Group announced a strategic leadership transition as Ruben Minski, founder and CEO of Procaps prepares to transition from the role of Chief Executive Officer to focus exclusively on his role as Executive Chairman of the Board, and the appointment of Jose Antonio Vieira as the new Chief Executive Officer of Procaps Group.
Procaps Group, a leading integrated LatAm healthcare and pharmaceutical services company, announced it will report its results for the third quarter and nine months ended September 30, 2023, after market closes on Tuesday, November 14, 2023.
Procaps Group, a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced the appointment of one new member to its Board of Directors.
OCYONBIO Announces Strategic Agreement with Marchesini Group USA for the Purchase of Filling and Packaging Equipment, Providing Vital Capabilities for Clients
OCYONBIO, a contract development and manufacturing organization focused on advanced therapies, announced a strategic agreement with Marchesini Group, a leading global provider of sterile filling and packaging solutions for pharmaceutical and Biotech companies.
Genomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange declaring a cash dividend of $0.196080 Mexican pesos per share on its common stock representing a total amount of $ 200,001,600.00 M.N., payable to shareholders of record at the close of business on September 29, 2023.
Procaps Group, S.A., a leading integrated international healthcare and pharmaceutical services company, announced its financial results for the three months ended June 30, 2023 and the six months ended June 30, 2023.
Procaps Group, S.A. announced the availability of a new white paper focused on gummy products, its revolutionary gummy technology, titled “Revolutionary Gummy Technology That Solves for The Supply Chain Constraints of Other Gummy Formats and Enhances Consumer Experience”.
Genomma Lab Internacional Informs the Voluntarily Prepayment of the Second Tranche of Its IFC Secured Loan
Genomma Lab Internacional, S.A.B. de C.V., one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, announced that on August 04, 2023 it has voluntarily prepaid the total amortization for the second tranche of its IFC secured loan.
Genomma Lab Manufacturing Facility Granted Cofepris Operating License for All Its Pharma / OTC Manufacturing Lines
Genomma Lab Internacional, S.A.B. de C.V. announced that the Mexican Ministry of Health's Federal Committee for Protection from Sanitary Risks has granted its approval of the sanitary license for the oral liquids, topical liquids and tablet coatings operations at Genomma Lab's Medicinas y Medicamentos Nacionales, S.A. de C.V. manufacturing facility in the State of Mexico.
Ginkgo Bioworks and the Government of the Republic of Panama Announce Plans to Establish New Biosecurity Capabilities
Ginkgo Bioworks, the leading horizontal platform for cell programming and biosecurity, and the Government of the Republic of Panama's Gorgas Memorial Institute for Health Studies, announced that they have entered into a Memorandum of Understanding with the intent to develop and implement new biosecurity capabilities in Latin America.
CDI Laboratories Inc., the Seromics™ company, announced that Barney E. Saunders Ph.D. has been appointed Chief Executive Officer.
Genomma Lab Internacional, S.A.B. de C.V., announced that it will report its Second Quarter 2023 results on Wednesday, July 26, 2023 after the Mexican Market close.